Antiepileptic drug withdrawal in juvenile myoclonic epilepsy.


Journal

Acta neurologica Scandinavica
ISSN: 1600-0404
Titre abrégé: Acta Neurol Scand
Pays: Denmark
ID NLM: 0370336

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 17 08 2018
revised: 08 10 2018
accepted: 25 10 2018
pubmed: 1 11 2018
medline: 23 2 2019
entrez: 1 11 2018
Statut: ppublish

Résumé

Withdrawal of antiepileptic drugs (AEDs) has been discouraged in juvenile myoclonic epilepsy (JME). However, impulsivity as a consequence of executive dysfunction in JME may influence treatment adherence. The aim of the present study was to assess how common withdrawal of AEDs is in a large and representative JME group. Patients with genetic generalized epilepsy (GGE) were identified through a retrospective search of medical records at Drammen Hospital, Norway, and invited to a clinical interview. Information related to AED withdrawal was analyzed in those classified as JME. A total of 132 patients with GGE were interviewed (87 JME). Thirty-five patients with JME (40%) discontinued AEDs, of which 74% did so without consulting a doctor. The rate of self-withdrawal was significantly higher in JME than in other types of GGE. Having a parent with psychosocial difficulties was significantly over-represented in the JME self-withdrawal group. Twelve of those who discontinued AEDs (34%) were free from generalized tonic-clonic seizures (GTCS) and without antiepileptic drugs >1 year. All but one of them withdrew AEDs without consulting a doctor. Age at first motor seizure was significantly higher in those with a favorable outcome of AED withdrawal. Self-withdrawal of AEDs is common in JME, especially in those with troublesome conditions at home. However, about 1/3 may remain free from GTCS without AEDs. The findings indicate a need for a stronger follow-up with appropriate information about the prognosis of the disorder.

Identifiants

pubmed: 30378684
doi: 10.1111/ane.13042
doi:

Substances chimiques

Anticonvulsants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

192-198

Subventions

Organisme : Vestre Viken Hospital Trust

Informations de copyright

© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Marte Syvertsen (M)

Department of Neurology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Ida Fløgstad (I)

Programme for Pharmacy, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.

Ulla Enger (U)

Department of Neurology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway.

Cecilie Johannessen Landmark (CJ)

Programme for Pharmacy, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.
The National Center for Epilepsy, Oslo University Hospital, Oslo, Norway.
Department of Pharmacology, Section for Clinical Pharmacology, The National Center for Epilepsy, Oslo University Hospital, Oslo, Norway.

Jeanette Koht (J)

Department of Neurology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH